MeroEasy is a medical reference tool for calculating Meropenem dosages and modeling pharmacokinetic formulas for adult patients.
The App DNA
What makes this app unique?
The app serves as an educational aid for medical professionals to estimate dosage influences, though its long-term inactivity undermines its reliability as a clinical reference.
For Medical professionals and students requiring educational tools for calculating Meropenem dosages.
What does it look like?
Key features
Calculates dosages for intermittent and continuous application methods.
Provides educational context on pharmacokinetic formulas for adult patients.
How much does it cost?
The app is distributed as a free utility with no visible monetization or subscription gates.
Velocity
Dormant developmentopaqueShow more...
MeroEasy has reached a zombie state, with no updates recorded in the last 955 days. The development history shows only a single minor release in the provided window, indicating a complete cessation of active maintenance or feature development. There is no evidence of ongoing support or operational activity for the platform.
Who built it?
Bundesverband Deutscher Krankenhausapotheker (ADKA) e.V.
3 apps tracked · Medical
PipEasy
VancoEasyUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for MeroEasy
How's the Medical market?
MeroEasy occupies a niche in the medical education category, though its position is currently static due to a lack of updates for over 950 days.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for MeroEasy
Where is it heading?
The clinical reference market demands high-frequency validation to match evolving medical guidelines. MeroEasy's lack of activity since early 2024 leaves it exposed to obsolescence, as users will naturally migrate to tools that demonstrate active clinical oversight.
- The 31-month update gap indicates the project is in a terminal state, which erodes professional trust in the tool's clinical accuracy.
The SWOT
- Professional authority of ADKA e.V. provides a trust-based barrier
- Updating pharmacokinetic guidelines could restore professional utility
Next best moves
Audit clinical data accuracy because the 31-month update gap risks outdated pharmacokinetic modeling → ensure safety baseline
+ 1 more prioritized moveThe counter-intuitive read
The app's professional backing by ADKA e.
Read the full takeBottom line
The 31-month development silence invalidates MeroEasy as a reliable clinical reference, as medical standards evolve faster than this maintenance cycle allows.
Unlock 1 critical friction, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated